FDA advisory committee recommends approval of gout drug lesinurad, with caveats

Members of the Food and Drug Administration’s Arthritis Advisory Committee have voted in favor of recommending approval of the investigational uricosuric drug lesinurad at 200 mg/day for the proposed...